Elanco Animal Health (Elanco Animal Health) Interest Expense : $-277 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Elanco Animal Health Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Elanco Animal Health's interest expense for the three months ended in Dec. 2023 was $ -67 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-277 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Elanco Animal Health's Operating Income for the three months ended in Dec. 2023 was $ 10 Mil. Elanco Animal Health's Interest Expense for the three months ended in Dec. 2023 was $ -67 Mil. Elanco Animal Health's Interest Coverage for the quarter that ended in Dec. 2023 was 0.15. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Elanco Animal Health Interest Expense Historical Data

The historical data trend for Elanco Animal Health's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elanco Animal Health Interest Expense Chart

Elanco Animal Health Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-79.00

-150.00

-236.00

-241.00

-277.00

Elanco Animal Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-62.00	-64.00	-74.00	-72.00	-67.00

Elanco Animal Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-277 Mil.

Elanco Animal Health (NYSE:ELAN) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Elanco Animal Health's Interest Expense for the three months ended in Dec. 2023 was $-67 Mil. Its Operating Income for the three months ended in Dec. 2023 was $10 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $5,736 Mil.

Elanco Animal Health's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	10	/	-67
	=	0.15

The higher the ratio, the stronger the company's financial strength is.

Elanco Animal Health (Elanco Animal Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanco Animal Health Inc (NYSE:ELAN) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

5EA:Germany

Address

2500 Innovation Way, Greenfield, IN, USA, 46140

Website

https://www.elanco.com

Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company's operations are conducted globally and sell its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

Executives

Grace Mcardle	officer: EVP, MANUFACTURING AND QUALITY	2500 INNOVATION WAY, GREENFIELD IN 46140
Timothy J Bettington	officer: See remarks	C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
R David Hoover	director	C/O EDGEWELL PERSONAL CARE COMPANY, 1350 TIMBERLAKE MANOR PARKWAY, CHESTERFIELD MO 63017
Jeffrey N Simmons	director, officer: Pres., Chief Executive Officer	2500 INNOVATION WAY, GREENFIELD IN 46140
John P Bilbrey	director
Rajeev A. Modi	officer: See Remarks	2500 INNOVATION WAY, GREENFIELD IN 46140
Paul Herendeen	director	C/O BAUSCH HEALTH COMPANIES INC., 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Michael J Harrington	director	LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Brabander Ellen De	officer: See Remarks	2500 INNOVATION WAY, GREENFIELD IN 46140
Marcela A. Kirberger	officer: Ex VP, Gen Counsel & Corp Sec	C/O ELANCO ANIMAL HEALTH INCORPORATED, 2500 INNOVATION WAY, GREENFIELD IN 46140
Art A Garcia	director	11690 N.W. 105TH STREET, MIAMI FL 33178
William F Doyle	director
Uncas Gp Llc	director	250 WEST 55TH STREET, 34TH FLOOR, NEW YORK NY 10019
Sachem Head Capital Management Lp	director	250 WEST 55TH STREET, 34TH FLOOR, NEW YORK NY 10019
Scott D. Ferguson	director	250 WEST 55TH STREET, 34TH FLOOR, NEW YORK NY 10019